Novavax, Inc. (NVAX)
8.855
-0.08
(-0.95%)
USD |
NASDAQ |
Aug 24, 16:00
8.86
0.00 (0.00%)
After-Hours: 20:00
Novavax Shareholders Equity (Quarterly) : -190.71M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -190.71M |
| March 31, 2026 | -144.76M |
| December 31, 2025 | -127.75M |
| September 30, 2025 | -156.67M |
| June 30, 2025 | 37.62M |
| March 31, 2025 | -75.64M |
| December 31, 2024 | -623.84M |
| September 30, 2024 | -526.44M |
| June 30, 2024 | -431.71M |
| March 31, 2024 | -867.08M |
| December 31, 2023 | -716.93M |
| September 30, 2023 | -678.35M |
| June 30, 2023 | -754.52M |
| March 31, 2023 | -895.58M |
| December 31, 2022 | -634.08M |
| September 30, 2022 | -565.98M |
| June 30, 2022 | -416.95M |
| March 31, 2022 | 65.32M |
| December 31, 2021 | -351.67M |
| September 30, 2021 | 461.34M |
| June 30, 2021 | 745.56M |
| March 31, 2021 | 1.039B |
| December 31, 2020 | 627.21M |
| September 30, 2020 | 306.26M |
| June 30, 2020 | 384.35M |
| Date | Value |
|---|---|
| March 31, 2020 | -23.97M |
| December 31, 2019 | -186.02M |
| September 30, 2019 | -189.84M |
| June 30, 2019 | -185.49M |
| March 31, 2019 | -150.58M |
| December 31, 2018 | -167.94M |
| September 30, 2018 | -126.68M |
| June 30, 2018 | -87.71M |
| March 31, 2018 | -99.37M |
| December 31, 2017 | -101.73M |
| September 30, 2017 | -74.15M |
| June 30, 2017 | -59.06M |
| March 31, 2017 | -29.10M |
| December 31, 2016 | -5.546M |
| September 30, 2016 | 49.78M |
| June 30, 2016 | 110.12M |
| March 31, 2016 | 185.43M |
| December 31, 2015 | 292.67M |
| September 30, 2015 | 367.02M |
| June 30, 2015 | 387.60M |
| March 31, 2015 | 399.71M |
| December 31, 2014 | 229.62M |
| September 30, 2014 | 261.65M |
| June 30, 2014 | 281.73M |
| March 31, 2014 | 191.06M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Moderna, Inc. | 6.761B |
| Merck & Co., Inc. | 41.93B |
| Pfizer Inc. | 85.19B |
| Recursion Pharmaceuticals, Inc. | 915.00M |
| Agenus, Inc. | -199.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 955.58M |
| Total Liabilities (Quarterly) | 1.146B |
| Debt to Equity Ratio | -1.559 |
| Current Ratio | 2.333 |
| Net Debt Paydown Yield | -0.88% |